Bristol-Myers Squibb 2018 JP Morgan Healthcare Conference

Bristol-Myers Squibb presented at the JP Morgan Healthcare Conference on January 9, 2018, outlining its strategic foundation as a diversified specialty biopharmaceutical company combining the best of biotech innovation with established pharmaceutical operations. The presentation addressed the company's focused and integrated approach to developing treatments for serious diseases.